Serious bacterial infection in recently immunized young febrile infants

Margaret Wolff1, Richard Bachur1

  • 1From the Department of Medicine (MW, RB) and the Division of Emergency Medicine (RB), Children's Hospital Boston, Harvard Medical School, Boston, MA.

Insights

Febrile infants receiving immunizations have a lower risk of serious bacterial infection (SBI), especially within 24 hours. However, urinary tract infections (UTI) remain a risk, warranting urine testing in infants presenting shortly after vaccination.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Febrile infants without a clear source of infection require careful evaluation for serious bacterial infections (SBI).
  • Recent immunizations can alter the clinical presentation and diagnostic considerations in febrile infants.

Purpose of the Study:

  • To determine the prevalence of SBI in febrile infants aged 6-12 weeks who received immunizations within 72 hours.
  • To compare SBI rates in infants with and without recent immunizations.

Main Methods:

  • Retrospective medical record review of 1,978 febrile infants (age 6-12 weeks) presenting to a pediatric emergency department.
  • Infants categorized into recent immunization (RI) and no recent immunization (NRI) groups based on vaccination within 72 hours prior to presentation.
  • SBI defined by positive blood and/or urine cultures.

Main Results:

  • Overall SBI prevalence was 6.6%.
  • SBI prevalence was lower in infants with recent immunizations (2.8%) compared to those without (7.0%).
  • Infants vaccinated within 24 hours had a significantly lower SBI prevalence (0.6%), with all identified SBIs being UTIs.

Conclusions:

  • The risk of SBI is reduced in the 24 hours following infant immunizations.
  • Urinary tract infections (UTIs) are a significant concern in febrile infants presenting within 24 hours post-immunization.
  • Consider urine testing for febrile infants presenting within 24 hours of vaccination; manage those presenting >24 hours post-vaccination similarly to unvaccinated infants.
Abstract

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Vaccinations01:51

Vaccinations

Overview
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...